Simbolo, Michele
 Distribuzione geografica
Continente #
EU - Europa 1864
NA - Nord America 1477
AS - Asia 709
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 4064
Nazione #
US - Stati Uniti d'America 1469
GB - Regno Unito 720
CN - Cina 658
IT - Italia 355
SE - Svezia 202
IE - Irlanda 184
FR - Francia 179
DE - Germania 87
FI - Finlandia 38
UA - Ucraina 34
VN - Vietnam 26
BE - Belgio 24
AT - Austria 14
IR - Iran 10
RU - Federazione Russa 10
TR - Turchia 8
AU - Australia 6
CA - Canada 6
NL - Olanda 5
AL - Albania 2
BR - Brasile 2
ES - Italia 2
EU - Europa 2
IN - India 2
JP - Giappone 2
LV - Lettonia 2
NO - Norvegia 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
ID - Indonesia 1
LK - Sri Lanka 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
Totale 4064
Città #
Southend 691
Chandler 465
Dublin 180
Verona 172
Ann Arbor 146
Woodbridge 143
Jacksonville 134
Beijing 114
Jinan 84
Redmond 78
Lawrence 71
Princeton 71
Wilmington 67
Shenyang 62
Nanjing 52
Ashburn 35
Tianjin 34
Zhengzhou 33
Bologna 32
Hebei 32
Houston 31
Haikou 28
Ningbo 27
Nanchang 26
Brussels 24
Changsha 23
Hangzhou 21
Taizhou 19
Dearborn 18
Falls Church 16
Guangzhou 16
Jiaxing 15
Taiyuan 15
Dong Ket 14
Redwood City 14
Vienna 14
Norwalk 12
Fuzhou 10
Shanghai 8
Lanzhou 7
Auburn Hills 6
Boydton 6
Fairfield 6
Milan 6
San Francisco 5
Zanjan 5
Bressanone 4
Düsseldorf 4
Lancaster 4
Los Angeles 4
Melbourne 4
Boardman 3
Chicago 3
Menlo Park 3
Pieve di Soligo 3
Riva 3
Sacramento 3
Seattle 3
Toronto 3
Villafranca Di Verona 3
Bari 2
Castelnuovo 2
Clearwater 2
Des Moines 2
Kashan 2
Kharkov 2
Rome 2
Roverbella 2
San Diego 2
Sossano 2
Toledo 2
Varese 2
Winnipeg 2
Xiangfen 2
Amsterdam 1
Andover 1
Augusta 1
Barletta 1
Berlin 1
Bolzano 1
Borås 1
Bovolone 1
Brescia 1
Buccinasco 1
Buenos Aires 1
Caserta 1
Castelfranco Veneto 1
Chaoyang 1
Charlotte 1
Colombo 1
Costa Mesa 1
Easton 1
Fiorano Modenese 1
Frankfurt am Main 1
Glenn Dale 1
Groningen 1
Hefei 1
Helsinki 1
Islamabad 1
Jakarta 1
Totale 3189
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 138
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 133
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 122
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 118
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 115
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 105
Reporting tumor molecular heterogeneity in histopathological diagnosis 105
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 104
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 100
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 100
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 91
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 88
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 86
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes 80
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 79
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 74
Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing 74
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 72
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 72
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy 71
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 71
Techniques and New Diagnostic Technologies (Limitations, Applications) 69
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 68
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 64
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 63
New genomic landscapes and therapeutic targets for biliary tract cancers 62
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer 61
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 61
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 61
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 60
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 60
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 58
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 58
MULTIGENE MUTATIONAL PROFILING OF CHOLANGIOCARCINOMAS IDENTIFIES ACTIONABLE MOLECULAR SUBGROUPS 57
Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers 57
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 56
Exosomal miRNA signatures of pancreatic lesions 56
Il profilo molecolare 54
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 52
Comparative Lesions Analysis Through a Targeted Sequencing Approach 52
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 51
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 51
Collapse of the Plasmacytoid Dendritic Cells compartment in advanced cutaneous melanomas by components of the tumor cell secretome 48
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 46
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma 45
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 45
Metformin enhances cisplatin-induced apoptosis and prevents resistance to cisplatin in co-mutated KRAS/LKB1 Non-Small Cell Lung Cancer (NSCLC) 44
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 44
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology 43
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 40
Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma 38
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? 34
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 34
Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors 32
Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival 31
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 30
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 30
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 30
Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology 28
Exploring the molecular and biological background of lung neuroendocrine tumours 27
Molecular and Clinical Insights in Malignant Brenner Tumor of the Testis With Liver Metastases:A Case Report 27
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 27
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 26
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 24
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 24
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities 23
Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series 23
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 21
Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades 21
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 21
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 20
Metastasis of lung carcinoid in the thyroid gland after 18 years: it is never too late. A case report and review of the literature 17
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 15
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications 14
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 14
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 12
Lung Carcinoid Tumors: Histology and Ki-67, The Eternal Rivalry 3
Totale 4230
Categoria #
all - tutte 8410
article - articoli 7472
book - libri 0
conference - conferenze 450
curatela - curatele 0
other - altro 282
patent - brevetti 0
selected - selezionate 0
volume - volumi 206
Totale 16820


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018297 0000 00 79156 1628135
2018/2019396 18519529 2147 7713 272610
2019/2020600 49264518 5953 7835 41528064
2020/2021643 119972789 6347 1312 27217355
2021/2022813 762214468 4418 3650 371758144
2022/20231111 87168111254 125345 210 0000
Totale 4230